Pharmaceutical Industry

 

TessArray® Resequencing Pathogen Microarrays (RPM) are a paradigm shift in microbial detection and identification.

 

TessArray RPM Microarrays enable users to:

 

•   • Improve the speed, scope and accuracy of microbial identification

    • Reduce product manufacturing costs and cycle times for cell based compounds and vaccines

    • Reduce testing costs by combining several methodologies into one

    • Eliminate False Positives

 

Current technologies test for a limited number of pathogens at a time, resulting in the need for multiple tests. Multiple tests drive up cost, delay response, and can Increase error rates.

 

Microbial Detection Solution (MDS)

 

Our MDS can detect and definitively identify hundreds of microbial contaminants to six-sigma levels of accuracy in a single test from a single sample in less than a day.

 

The benefits of the MDS solution from TessArae® include:

 

•   • Reduced Cost and Dramatically Decreased Cycle Time

    • Detection of all Customer-Defined Organisms with One Test in Less than One Day

    • Identification of Specific Bacterial, Viral, and Fungal Contaminants From a Single Sample

    • Designed to Support Customer-Specific Maximum Daily Testing Needs

    • Minimal Human Intervention

    • Maximal Use of Automation/Robotics

    • On-Site Customer Training if Needed

    • Automated Report Generation

    • On-Line Results Storage & Results Available Electronically

 

In Summary, TessArae RPM Technology can offer reduced costs throughout the identification and intervention cycle.